Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Blissy Silk Pillowcases
Company hits snooze on promised marketing changes.
Alzheimer’s Association: Out of Place
Some things come with age. And some don’t.
Need a passport fast? Watchdog questions courier companies’ promises
Matt Gephardt, KSL.com
So Natural Coconut Water
Is this drink’s packaging whispering sweet nothings?
Thursday Night Football on Amazon Prime
Subscription streaming service isn’t the only way to catch the game.